ArticleFrontiers in oncology2022

Cost-Effectiveness of 12 First-Line Treatments for Patients With Advanced EGFR Mutated NSCLC in the United Kingdom and China.

Haijing Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.